Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Arvinas. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Arvinas.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Arvinas Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno giugno 18, 2025, Angela M Cacace, l'azienda CHIEF SCIENTIFIC OFFICER sold 2.58K condivisioni per $7.49 ciascuna.
- Il giorno giugno 24, 2025, Andrew Saik, l'azienda CHIEF FINANCIAL OFFICER sold 5.7K condivisioni per $7.61 ciascuna.
Statistiche sulla proprietà per Arvinas Inc
Numero di azioni emesse
73.418M
Azioni possedute dagli insider
2.637M
Percentuale posseduta dagli Insider
3.61%
Azioni possedute dagli investitori istituzionali
29.355M
Percentuale posseduta dagli investitori istituzionali
40.1%
Jun 24, 2025 | CHIEF FINANCIAL OFFICER | -5.70K | $7.61 | -$43.38K | SELL | -3.35% | 164.40K | Jun 24 | ||
Jun 18, 2025 | CHIEF SCIENTIFIC OFFICER | -2.58K | $7.49 | -$19.35K | SELL | -1.65% | 154.25K | Jun 17 | ||
Mar 19, 2025 | CHIEF MEDICAL OFFICER | -8.66K | $8.59 | -$74.37K | SELL | -7.30% | 110.02K | Mar 18 | ||
Feb 25, 2025 | CHIEF ACCOUNTING OFFICER | -1.21K | $16.75 | -$20.33K | SELL | -6.05% | 18.86K | Feb 24 | ||
Feb 25, 2025 | CHIEF SCIENTIFIC OFFICER | -4.21K | $16.70 | -$70.24K | SELL | -4.15% | 97.23K | Feb 24 | ||
Feb 25, 2025 | PRESIDENT, R&D | -9.02K | $16.71 | -$150.75K | SELL | -5.36% | 159.12K | Feb 24 | ||
Feb 25, 2025 | PRESIDENT AND CEO | -31.34K | $16.72 | -$523.88K | SELL | -2.64% | 1.16M | Feb 24 | ||
Nov 12, 2024 | CHIEF ACCOUNTING OFFICER | -460.00 | $22.39 | -$10.30K | SELL | -5.41% | 8.04K | Nov 08 - Nov 07 | ||
Feb 27, 2024 | PRESIDENT AND CEO | 119.25K | $47.05 | -$244.47K | GRANT | 13.00% | 1.04M | Feb 23 | ||
Feb 27, 2024 | CHIEF FINANCIAL OFFICER | -1.70K | $47.05 | -$80.08K | SELL | -0.93% | 181.92K | Feb 23 | ||
Feb 27, 2024 | CHIEF MEDICAL OFFICER | 37.55K | $47.05 | -$79.94K | GRANT | 125.32% | 67.52K | Feb 23 | ||
Feb 27, 2024 | CHIEF SCIENTIFIC OFFICER | 37.55K | $47.05 | -$80.03K | GRANT | 34.14% | 147.52K | Feb 23 | ||
Aug 14, 2023 | CHIEF MEDICAL OFFICER | 2.69K | $24.39 | -$32.29K | SELL-OPTIONS | 9.85% | 29.96K | Aug 11 | ||
Mar 03, 2023 | CHIEF SCIENTIFIC OFFICER | 1.63K | $29.53 | -$31.04K | SELL-OPTIONS | 1.63% | 101.72K | Mar 01 | ||
Mar 03, 2023 | PRESIDENT AND CEO | 11.63K | $29.53 | -$173.58K | SELL-OPTIONS | 1.28% | 917.43K | Mar 01 | ||
Mar 03, 2023 | CHIEF FINANCIAL OFFICER | 3.05K | $29.53 | -$51.53K | SELL-OPTIONS | 1.69% | 183.62K | Mar 01 | ||
Aug 16, 2022 | CHIEF MEDICAL OFFICER | 2.75K | $68.99 | -$86.79K | SELL-OPTIONS | 50.94% | 8.15K | Aug 12 | ||
Apr 18, 2022 | DIRECTOR | -4.77K | $41.22 | -$1.13M | SELL | -19.28% | 19.98K | Apr 14 | ||
Mar 15, 2022 | CHIEF FINANCIAL OFFICER | 0.00 | $43.00 | -$810.00K | SELL-OPTIONS | 0.00% | 161.45K | Mar 11 | ||
Mar 04, 2022 | CHIEF SCIENTIFIC OFFICER | 1.82K | $63.94 | -$55.56K | SELL-OPTIONS | 2.21% | 83.96K | Mar 04 | ||
Mar 04, 2022 | CHIEF FINANCIAL OFFICER | 3.20K | $63.94 | -$101.86K | SELL-OPTIONS | 2.02% | 161.45K | Mar 04 | ||
Mar 04, 2022 | PRESIDENT AND CEO | 11.49K | $63.94 | -$385.17K | SELL-OPTIONS | 1.38% | 843.82K | Mar 04 | ||
Feb 17, 2022 | CHIEF SCIENTIFIC OFFICER | 0.00 | $46.19 | -$1.07M | SELL-OPTIONS | 0.00% | 78.64K | Feb 15 | ||
Jan 19, 2022 | DIRECTOR | -4.77K | $40.78 | -$1.12M | SELL | -16.17% | 24.75K | Jan 14 | ||
Jan 04, 2022 | CHIEF MEDICAL OFFICER | 0.00 | $61.07 | -$781.66K | SELL-OPTIONS | 0.00% | 5.40K | Dec 30 | ||
Dec 21, 2021 | CHIEF FINANCIAL OFFICER | 0.00 | $43.00 | -$810.00K | SELL-OPTIONS | 0.00% | 158.25K | Dec 17 | ||
Dec 16, 2021 | DIRECTOR | -355.70K | $67.00 | -$23.83M | SELL | -65.70% | 185.69K | Dec 14 - Dec 16 | ||
Nov 17, 2021 | CHIEF SCIENTIFIC OFFICER | 0.00 | $50.67 | -$1.33M | SELL-OPTIONS | 0.00% | 78.64K | Nov 15 | ||
Nov 15, 2021 | DIRECTOR | -134.31K | $85.83 | -$11.53M | SELL | -19.88% | 541.39K | Nov 10 - Nov 15 | ||
Nov 09, 2021 | DIRECTOR | -153.66K | $61.29 | -$15.46M | SELL | -18.53% | 675.70K | Nov 05 - Nov 09 | ||
Nov 03, 2021 | PRESIDENT AND CEO | 0.00 | $52.07 | -$2.89M | SELL-OPTIONS | 0.00% | 832.33K | Nov 01 | ||
Sep 27, 2021 | DIRECTOR | -68.80K | $87.41 | -$6.01M | SELL | -3.82% | 1.73M | Sep 03 - Sep 07 | ||
Sep 27, 2021 | DIRECTOR | -190.56K | $86.25 | -$16.44M | SELL | -9.56% | 1.80M | Aug 31 - Sep 02 | ||
Sep 27, 2021 | DIRECTOR | -115.58K | $85.72 | -$9.91M | SELL | -5.48% | 1.99M | Aug 26 - Aug 30 | ||
Sep 27, 2021 | DIRECTOR | -25.07K | $85.95 | -$2.15M | SELL | -1.17% | 2.11M | Aug 23 - Aug 25 | ||
Aug 27, 2021 | DIRECTOR | -29.94K | $85.01 | -$2.55M | SELL | -32.76% | 61.46K | Aug 25 - Aug 26 | ||
Aug 18, 2021 | CHIEF SCIENTIFIC OFFICER | 0.00 | $51.65 | -$1.43M | SELL-OPTIONS | 0.00% | 78.64K | Aug 16 | ||
Aug 16, 2021 | CHIEF MEDICAL OFFICER | 2.65K | $90.54 | -$123.40K | SELL-OPTIONS | 96.15% | 5.40K | Aug 12 | ||
Aug 13, 2021 | DIRECTOR | -10.83K | $90.03 | -$974.84K | SELL | -10.59% | 91.40K | Aug 11 - Aug 13 | ||
Aug 04, 2021 | PRESIDENT AND CEO | 0.00 | $56.91 | -$3.76M | SELL-OPTIONS | 0.00% | 827.64K | Aug 02 | ||
Jul 30, 2021 | CHIEF FINANCIAL OFFICER | 0.00 | $58.00 | -$1.45M | SELL-OPTIONS | 0.00% | 158.25K | Jul 28 | ||
Jul 02, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $62.03 | -$586.20K | SELL-OPTIONS | 0.00% | 2.75K | Jun 30 | ||
Jun 11, 2021 | PRESIDENT AND CEO | 0.00 | $48.73 | -$2.92M | SELL-OPTIONS | 0.00% | 827.64K | Jun 09 - Jun 10 | ||
Apr 07, 2021 | CHIEF SCIENTIFIC OFFICER | 0.00 | $41.40 | -$1.27M | SELL-OPTIONS | 0.00% | 78.64K | Apr 05 | ||
Mar 02, 2021 | CHIEF SCIENTIFIC OFFICER | 1.79K | $77.45 | -$69.24K | SELL-OPTIONS | 2.33% | 78.64K | Mar 02 | ||
Mar 02, 2021 | CHIEF FINANCIAL OFFICER | 2.57K | $77.45 | -$172.02K | SELL-OPTIONS | 1.65% | 158.25K | Mar 02 | ||
Mar 02, 2021 | PRESIDENT AND CEO | 10.02K | $53.10 | -$610.53K | SELL-OPTIONS | 0.61% | 1.65M | Jun 30 - Mar 02 | ||
Feb 18, 2021 | PRESIDENT AND CEO | 0.00 | $47.39 | -$2.76M | SELL-OPTIONS | 0.00% | 816.20K | Feb 16 | ||
Feb 18, 2021 | CHIEF FINANCIAL OFFICER | 0.00 | $47.23 | -$2.62M | SELL-OPTIONS | 0.00% | 154.78K | Feb 16 | ||
Feb 18, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $51.96 | -$1.02M | SELL-OPTIONS | 0.00% | 2.75K | Feb 16 | ||
Dec 21, 2020 | — | 142.86K | $70.00 | $10.00M | PURCHASE | 21.01% | 822.86K | Dec 18 | ||
Nov 12, 2020 | — | 8.33K | $23.99 | $199.91K | PURCHASE | 24.23% | 42.72K | Nov 09 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.